SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Eadon JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48: 526535.
  • 2
    Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006; 130: 10301038.
  • 3
    Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol. 2008; 6: 993998.
  • 4
    Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006; 130: 10391046.
  • 5
    Farraye F, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010; 138: 746774.
  • 6
    Farraye FA, Odze RD, Eaden J, et al. AGA Institute Medical Position Panel on diagnosis and management of colorectal neoplasia in inflammatory bowel disease. AGA medical position statement on the diagnosis and management of colorectal dysplasia in inflammatory bowel disease. Gastroenterology. 2010; 138: 738745.
  • 7
    Itzkowitz SH, Present DH; Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 314321.
  • 8
    IBM SPSS Manual. Confirmatory Factor Analysis in SPSS Factor [IBM SPSS Website]. May 18, 2011. Available at: http://www.304.ibd.com/support/docview. Accessed July 4, 2011.
  • 9
    IBM SPSS Manual. Multiple Group Factor Analysis in SPSS [IBM SPSS Website]. May 18, 2011. Available at: http://www.304.ibd.com/support/docview. Accessed July 4, 2011.
  • 10
    DeVellis, RF. Scale Development: Theory and Applications. 2nd ed. Thousand Oaks, CA: Sage Publications; 2003.
  • 11
    Irvine EJ, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators, Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996; 91: 15711578.
  • 12
    Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease: Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994; 106: 287296.
  • 13
    Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008; 16: CD000165.
  • 14
    Shaheen NJ, Green B, Medapalli RK, et al. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology. 2005; 129: 429436.
  • 15
    Siegel CA, Schwartz LM, Woloshin S, et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis. 2010; 16: 16581662.
  • 16
    Baars JE, Siegel CA, van't Spijker A, et al. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis. 2010; 42: 777784.